DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
0.8000
-0.0060 (-0.74%)
At close: Mar 28, 2025, 4:00 PM
0.7949
-0.0051 (-0.64%)
After-hours: Mar 28, 2025, 7:55 PM EDT
DURECT Market Cap
DURECT has a market cap or net worth of $24.83 million as of March 28, 2025. Its market cap has decreased by -26.31% in one year.
Market Cap
24.83M
Enterprise Value
15.24M
1-Year Change
-26.31%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since September 28, 2000, DURECT's market cap has decreased from $660.10M to $24.83M, a decrease of -96.24%. That is a compound annual growth rate of -12.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 24.80M | 6.44% |
Dec 31, 2024 | 23.30M | 32.39% |
Dec 29, 2023 | 17.60M | -77.66% |
Dec 30, 2022 | 78.80M | -64.87% |
Dec 31, 2021 | 224.30M | -46.67% |
Dec 31, 2020 | 420.60M | -42.46% |
Dec 31, 2019 | 731.00M | 833.59% |
Dec 31, 2018 | 78.30M | -42.80% |
Dec 29, 2017 | 136.90M | -26.28% |
Dec 30, 2016 | 185.70M | -30.29% |
Dec 31, 2015 | 266.40M | 196.99% |
Dec 31, 2014 | 89.70M | -49.21% |
Dec 31, 2013 | 176.60M | 118.56% |
Dec 31, 2012 | 80.80M | -21.71% |
Dec 30, 2011 | 103.20M | -65.58% |
Dec 31, 2010 | 299.80M | 39.90% |
Dec 31, 2009 | 214.30M | -22.86% |
Dec 31, 2008 | 277.80M | -41.66% |
Dec 31, 2007 | 476.20M | 55.67% |
Dec 29, 2006 | 305.90M | 13.25% |
Dec 30, 2005 | 270.10M | 58.98% |
Dec 31, 2004 | 169.90M | 32.84% |
Dec 31, 2003 | 127.90M | 25.52% |
Dec 31, 2002 | 101.90M | -81.72% |
Dec 31, 2001 | 557.50M | -0.16% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |